About Pharma-Bio Serv (OTCMKTS:PBSV)
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm with a laboratory testing facility in Puerto Rico, the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It also offers microbiological and chemical testing services through its lab; and technical trainings/seminars. The company markets its services through industry trade shows, professional conventions, industry publications, and seminars. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryN/A
SectorBusiness Services
SymbolOTCMKTS:PBSV
CUSIPN/A
Phone787-278-2709
Debt
Debt-to-Equity RatioN/A
Current Ratio13.30%
Quick Ratio13.30%
Price-To-Earnings
Trailing P/E Ratio-7.50
Forward P/E Ratio-3.75
P/E GrowthN/A
Sales & Book Value
Annual Sales$15.58 million
Price / Sales0.67
Cash FlowN/A
Price / CashN/A
Book Value$0.90 per share
Price / Book0.50
Profitability
EPS (Most Recent Fiscal Year)($0.06)
Net Income$-1,410,000.00
Net Margins-23.46%
Return on Equity-18.22%
Return on Assets-16.45%
Miscellaneous
Employees155
Outstanding Shares23,060,000
Pharma-Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions
What is Pharma-Bio Serv's stock symbol?
Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."
How were Pharma-Bio Serv's earnings last quarter?
Pharma-Bio Serv (OTCMKTS:PBSV) issued its earnings results on Monday, January, 29th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $3.63 million during the quarter. Pharma-Bio Serv had a negative return on equity of 18.22% and a negative net margin of 23.46%. View Pharma-Bio Serv's Earnings History.
When is Pharma-Bio Serv's next earnings date?
Who are some of Pharma-Bio Serv's key competitors?
Some companies that are related to Pharma-Bio Serv include Resaas Services (RSASF), Trxade Group (TRXD), Noble Roman's Pizza (NROM), Black Ridge Oil & Gas (ANFC), Vernalis (VNLPY), Sierra Monitor (SRMC), Windtree Therapeutics (WINT), Pacific Drilling (PACDQ), Acorn Energy (ACFN), Atna Resources (ATNAQ), Acura Pharmaceuticals (ACUR), Deep Down (DPDW), Omni Lite Industries Canada (OLNCF), Destiny Media Tech (DSNY), B456 Systems (AONEQ), Premier (PRHL), P10 (PIOIQ) and Connecture (CNXR).
Who are Pharma-Bio Serv's key executives?
Pharma-Bio Serv's management team includes the folowing people:
- Ms. Elizabeth Plaza, Founder, Chairman & Sr. Strategic Consultant (Age 54)
- Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 47)
- Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin., Principal Accounting Officer and Sec. (Age 58)
Has Pharma-Bio Serv been receiving favorable news coverage?
News headlines about PBSV stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pharma-Bio Serv earned a coverage optimism score of 0.09 on Accern's scale. They also assigned news articles about the company an impact score of 44.49 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Pharma-Bio Serv?
Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pharma-Bio Serv's stock price today?
One share of PBSV stock can currently be purchased for approximately $0.45.
How big of a company is Pharma-Bio Serv?
Pharma-Bio Serv has a market capitalization of $10.38 million and generates $15.58 million in revenue each year. The company earns $-1,410,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Pharma-Bio Serv employs 155 workers across the globe.
How can I contact Pharma-Bio Serv?
Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]
MarketBeat Community Rating for Pharma-Bio Serv (PBSV)
MarketBeat's community ratings are surveys of what our community members think about Pharma-Bio Serv and other stocks. Vote "Outperform" if you believe PBSV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBSV will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pharma-Bio Serv (OTCMKTS:PBSV) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 4/19/2016 forward)
Pharma-Bio Serv (OTCMKTS:PBSV) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Pharma-Bio Serv (OTCMKTS PBSV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 51.20%
Pharma-Bio Serv (OTCMKTS PBSV) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/11/2014 | Kirk Wheeler Michel | Director | Sell | 9,170 | $2.06 | $18,890.20 | |  |
(Data available from 1/1/2013 forward)
Pharma-Bio Serv (OTCMKTS PBSV) News Headlines
| Source: |
|
Pharma-Bio Serv (OTCMKTS:PBSV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Pharma-Bio Serv (OTCMKTS PBSV) Stock Chart for Thursday, April, 19, 2018
Loading chart…
